puromycin aminonucleoside has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demirci, S; Kokturk, S; Oztürk, Z; Pekpak, M; Seckin, I; Sonmez, H; Uzunalan, M; Yaprak, E | 1 |
| Fujita, T; Inagi, R; Miyata, T; Nangaku, M; Tanaka, T | 1 |
2 other study(ies) available for puromycin aminonucleoside and Hypoxia
| Article | Year |
|---|---|
Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli.
Topics: Acute Disease; Albumins; Angiogenic Proteins; Animals; Chronic Disease; Creatinine; Disease Models, Animal; Humans; Hypoxia; Immunohistochemistry; Injections, Subcutaneous; Kidney Glomerulus; Male; Microscopy, Electron, Transmission; Neovascularization, Pathologic; Nephrosis; Platelet-Derived Growth Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2012 |
Hypoxia in renal disease with proteinuria and/or glomerular hypertension.
Topics: Animals; Animals, Genetically Modified; Antibiotics, Antineoplastic; Hypertension, Renal; Hypoxia; Ischemia; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Luciferases; Male; Proliferating Cell Nuclear Antigen; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Reperfusion Injury; Vascular Endothelial Growth Factor A | 2004 |